Mammographic Screening for Breast Cancer

A 44-year-old woman who is a new patient has no known current health problems and no family history of breast or ovarian cancer. Eighteen months ago, she had a normal screening mammogram. She recently read that mammograms may not help to prevent death from breast cancer and that “the patient should decide.” But she does not think she knows enough. She worries that there is a breast-cancer epidemic. What should her physician advise?

[1]  K. Kerlikowske,et al.  Mortality among women with ductal carcinoma in situ of the breast in the population-based surveillance, epidemiology and end results program. , 2000, Archives of internal medicine.

[2]  Phyllis J. Kornguth,et al.  Pain during mammography: characteristics and relationship to demographic and medical variables , 1996, PAIN®.

[3]  D Spiegelman,et al.  Validation of the Gail et al. model of breast cancer risk prediction and implications for chemoprevention. , 2001, Journal of the National Cancer Institute.

[4]  S. Feig.  Assessment of radiation risk from screening mammography , 1996, Cancer.

[5]  E A Sickles,et al.  Screening mammography in community practice: positive predictive value of abnormal findings and yield of follow-up diagnostic procedures. , 1995, AJR. American journal of roentgenology.

[6]  A. Miller.  Screening for breast cancer with mammography , 2001, The Lancet.

[7]  S Shapiro,et al.  Report of the International Workshop on Screening for Breast Cancer. , 1993, Journal of the National Cancer Institute.

[8]  J. Mayer,et al.  Rates and correlates of discomfort associated with mammography. , 2000, Radiology.

[9]  Peter C Gøtzsche,et al.  Is screening for breast cancer with mammography justifiable? , 2000, The Lancet.

[10]  F. J. Andrews,et al.  Pain during mammography: implications for breast screening programmes. , 2001, Australasian radiology.

[11]  E. Pisano,et al.  Screening behavior of women after a false-positive mammogram. , 1998, Radiology.

[12]  L. Fajardo,et al.  Correlation between breast parenchymal patterns and mammographers' certainty of diagnosis. , 1988, Investigative radiology.

[13]  J. Elmore,et al.  Breast Symptoms among Women Enrolled in a Health Maintenance Organization: Frequency, Evaluation, and Outcome , 1999, Annals of Internal Medicine.

[14]  A. Miller,et al.  Canadian National Breast Screening Study: 1. Breast cancer detection and death rates among women aged 40 to 49 years. , 1992, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.

[15]  T. Wobbes,et al.  Pain experienced by women attending breast cancer screening , 2000, Breast Cancer Research and Treatment.

[16]  Peter C Gøtzsche,et al.  Cochrane review on screening for breast cancer with mammography , 2001, The Lancet.

[17]  J. D. Johnson,et al.  Differences in evaluations of communication channels for cancer-related information , 1992, Journal of Behavioral Medicine.

[18]  D. Berry,et al.  Benefits and risks of screening mammography for women in their forties: a statistical appraisal. , 1998, Journal of the National Cancer Institute.

[19]  M. Skolnick,et al.  Statement of the American Society of Clinical Oncology : Genetic testing for cancer susceptibility. Commentaries , 1996 .

[20]  H. Welch,et al.  Using Autopsy Series To Estimate the Disease Reservoir for Ductal Carcinoma in Situ of the Breast: How Much More Breast Cancer Can We Find? , 1997, Annals of Internal Medicine.

[21]  Daniel S. Miller,et al.  Trends in self-reported use of mammograms (1989-1997) and Papanicolaou tests (1991-1997)--Behavioral Risk Factor Surveillance System. , 1999, MMWR. CDC surveillance summaries : Morbidity and mortality weekly report. CDC surveillance summaries.

[22]  G. Elwyn,et al.  One hundred years ago: Should milk be boiled? , 2002, BMJ : British Medical Journal.

[23]  Ingvar Andersson,et al.  Long-term effects of mammography screening: updated overview of the Swedish randomised trials , 2002, The Lancet.

[24]  B Fisher,et al.  Lumpectomy compared with lumpectomy and radiation therapy for the treatment of intraductal breast cancer. , 1993, The New England journal of medicine.

[25]  B. Trock,et al.  Psychological and behavioral implications of abnormal mammograms. , 1991, Annals of internal medicine.

[26]  D. Rutter,et al.  Discomfort and pain during mammography: description, prediction, and prevention. , 1992, British medical journal.

[27]  S. Taplin,et al.  Effect of estrogen replacement therapy on the specificity and sensitivity of screening mammography. , 1996, Journal of the National Cancer Institute.

[28]  N. Boyd,et al.  Case-control study of factors associated with failure to detect breast cancer by mammography. , 1992, Journal of the National Cancer Institute.

[29]  R Holland,et al.  Mammographically occult breast cancer: A pathologic and radiologic study , 1983, Cancer.

[30]  S. Seger.  Effect of false-positive mammograms on interval breast cancer screening in a health maintenance organization. , 2000, Journal of midwifery & women's health.

[31]  A. Basiński.  Review: High-quality studies do not show reductions in breast cancer mortality for women screened with mammography , 2000, ACP Journal Club.

[32]  Stephen W Duffy,et al.  Screening mammography re-evaluated , 2000, The Lancet.

[33]  C. Herman,et al.  Short-term cessation of hormone replacement therapy and improvement of mammographic specificity. , 1997, Journal of the National Cancer Institute.

[34]  R F Nease,et al.  Perceptions of breast cancer risk and screening effectiveness in women younger than 50 years of age. , 1995, Journal of the National Cancer Institute.

[35]  J. Elmore,et al.  Ten-year risk of false positive screening mammograms and clinical breast examinations. , 1998, The New England journal of medicine.

[36]  A. Berg,et al.  Screening for Breast Cancer: Recommendations and Rationale , 2002, Annals of Internal Medicine.

[37]  K. Kerlikowske,et al.  Incidence of and treatment for ductal carcinoma in situ of the breast. , 1996, JAMA.

[38]  Jo M. Kendrick,et al.  Quality Determinants of Mammography, Clinical Practice Guideline , 1995 .

[39]  H. Welch,et al.  Views on Breast Cancer Risk Patient-centered Decision Making Women ’ s Views on Breast Cancer Risk and Screening Mammography : A Qualitative Interview Study , 2001 .

[40]  J. Hendriks,et al.  Mammographic screening after the age of 65 years: Evidence for a reduction in breast cancer mortality , 1996, International journal of cancer.

[41]  S. Fletcher,et al.  Breast cancer screening among women in their forties: an overview of the issues. , 1997, Journal of the National Cancer Institute. Monographs.

[42]  K. Kerlikowske,et al.  Effect of age, breast density, and family history on the sensitivity of first screening mammography. , 1996, JAMA.

[43]  A. Gelfand,et al.  Predicting the cumulative risk of false-positive mammograms. , 2000, Journal of the National Cancer Institute.

[44]  E B Larson,et al.  Effect of postmenopausal hormonal replacement therapy on mammographic density and parenchymal pattern. , 1995, Radiology.

[45]  A. Miller,et al.  Canadian National Breast Screening Study: 2. Breast cancer detection and death rates among women aged 50 to 59 years. , 1992, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.

[46]  E White,et al.  Variation in mammographic breast density by time in menstrual cycle among women aged 40-49 years. , 1998, Journal of the National Cancer Institute.

[47]  R. Anderson,et al.  United States life tables, 1999. , 2002, National vital statistics reports : from the Centers for Disease Control and Prevention, National Center for Health Statistics, National Vital Statistics System.

[48]  Giovanni Parmigiani,et al.  BRCAPRO validation, sensitivity of genetic testing of BRCA1/BRCA2, and prevalence of other breast cancer susceptibility genes. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[49]  P. Goss,et al.  Estrogen and the risk of breast cancer. , 2001, The New England journal of medicine.

[50]  Screening mammography re-evaluated , 2000, The Lancet.